A Clinical Drug as the Three‐Photon Fluorescence Probe for In Vivo Microscopic Imaging of Mouse Kidney
Journal of Biophotonics · 2025
DOI: 10.1002/jbio.202400441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biophotonics, 2025. Verfasst von Weihang Geng und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Extreme Photonics and Instrumentations, Centre for Optical and Electromagnetic Research, College of Optical Science and Engin…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Kidney Tubules, Microscopy, Fluorescence, Multiphoton. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Dr. Li Dak Sum & Yip Yio Chin Development Fund for Regenerative Medicine, Zhejiang University.
Abstract (Originalsprache)
Three‐photon fluorescence (3PF) microscopy encounters significant challenges in biological research and clinical applications, primarily due to the limited availability of high‐performance probes. We took a shortcut by exploring the excellent 3PF property of berberine hydrochloride (BH), a clinically utilized drug derived from the traditional Chinese medicine, Coptis. Capitalizing on its renal metabolism characteristics, we employed BH for in vivo 3PF microscopic imaging of the mouse kidney. This approach enabled high‐resolution structural observation of renal tubules and facilitated the diagnosis of drug‐induced acute kidney injury (AKI) based on renal tubule morphology. The analytical capabilities of 3PF microscopy for renal physiology and pathological diagnosis suggest its potential for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Extreme Photonics and Instrumentations, Centre for Optical and Electromagnetic Research, College of Optical Science and Engineering, International Research Center for Advanced Photonics, Zhejiang…
- Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, China.
- Key Laboratory of Excited-State Materials of Zhejiang Province, Department of Chemistry, Zhejiang University, Hangzhou, China.
- School of Information and Electronic Engineering, Zhejiang Gongshang University, Hangzhou, China.
ORCID-Profile: Jun Qian
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Dr. Li Dak Sum & Yip Yio Chin Development Fund for Regenerative Medicine, Zhejiang University
Zitieren
APA
Geng, W., Xia, Q., He, M., Wang, Y., Zheng, Z., Qin, H., Wang, Y., Feng, J., & Qian, J. (2025). A Clinical Drug as the Three‐Photon Fluorescence Probe for In Vivo Microscopic Imaging of Mouse Kidney. Journal of Biophotonics. https://doi.org/10.1002/jbio.202400441
Vancouver
Geng W, Xia Q, He M, Wang Y, Zheng Z, Qin H, et al. A Clinical Drug as the Three‐Photon Fluorescence Probe for In Vivo Microscopic Imaging of Mouse Kidney. Journal of Biophotonics. 2025. doi:10.1002/jbio.202400441
BibTeX
@article{Geng2025,
author = {Geng, Weihang and Xia, Qiming and He, Mubin and Wang, Yi and Zheng, Zheng and Qin, Haiyan and Wang, Yalun and Feng, Jian and Qian, Jun},
title = {A Clinical Drug as the Three‐Photon Fluorescence Probe for In Vivo Microscopic Imaging of Mouse Kidney},
journal = {Journal of Biophotonics},
year = {2025},
doi = {10.1002/jbio.202400441}
}
EUVIMED